Global Hepatitis A Vaccine Market Research Report 2019 by Manufacturers, Regions, Types and Applications
Table of Contents
1 Executive Summary
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Hepatitis A Vaccine Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 Liver Inactivated Vaccine
- 2.1.2 Live Attenuated Vaccine
- 2.2 Overall Market Performance(Value)
- 2.2.1 Liver Inactivated Vaccine
- 2.2.2 Live Attenuated Vaccine
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Hospitals
- 3.1.2 Other Medical Institutions
4 Manufacturers Profiles/Analysis
- 4.1 GlaxoSmithKline
- 4.1.1 GlaxoSmithKline Profiles
- 4.1.2 GlaxoSmithKline Product Information
- 4.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Sales Value(Million USD), Price and Gross Profit
- 4.1.4 GlaxoSmithKline SWOT Analysis
- 4.2 Merck Sharp & Dohme Corp
- 4.2.1 Merck Sharp & Dohme Corp Profiles
- 4.2.2 Merck Sharp & Dohme Corp Product Information
- 4.2.3 Merck Sharp & Dohme Corp Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.2.4 Merck Sharp & Dohme Corp SWOT Analysis
- 4.3 SANOFI PASTEUR S.A
- 4.3.1 SANOFI PASTEUR S.A Profiles
- 4.3.2 SANOFI PASTEUR S.A Product Information
- 4.3.3 SANOFI PASTEUR S.A Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.3.4 SANOFI PASTEUR S.A SWOT Analysis
- 4.4 Norvatis
- 4.4.1 Norvatis Profiles
- 4.4.2 Norvatis Product Information
- 4.4.3 Norvatis Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.4.4 Norvatis SWOT Analysis
- 4.5 Crucell Switzerland AG(Berna+Crucell)
- 4.5.1 Crucell Switzerland AG(Berna+Crucell) Profiles
- 4.5.2 Crucell Switzerland AG(Berna+Crucell) Product Information
- 4.5.3 Crucell Switzerland AG(Berna+Crucell) Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.5.4 Crucell Switzerland AG(Berna+Crucell) SWOT Analysis
- 4.6 China Academy of Medical Sciences
- 4.6.1 China Academy of Medical Sciences Profiles
- 4.6.2 China Academy of Medical Sciences Product Information
- 4.6.3 China Academy of Medical Sciences Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.6.4 China Academy of Medical Sciences SWOT Analysis
- 4.7 Changchun Institute of Biological Products
- 4.7.1 Changchun Institute of Biological Products Profiles
- 4.7.2 Changchun Institute of Biological Products Product Information
- 4.7.3 Changchun Institute of Biological Products Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.7.4 Changchun Institute of Biological Products SWOT Analysis
- 4.8 Zhejiang Pukang
- 4.8.1 Zhejiang Pukang Profiles
- 4.8.2 Zhejiang Pukang Product Information
- 4.8.3 Zhejiang Pukang Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.8.4 Zhejiang Pukang SWOT Analysis
- 4.9 ChangSheng
- 4.9.1 ChangSheng Profiles
- 4.9.2 ChangSheng Product Information
- 4.9.3 ChangSheng Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.9.4 ChangSheng SWOT Analysis
- 4.10 Sinovac
- 4.10.1 Sinovac Profiles
- 4.10.2 Sinovac Product Information
- 4.10.3 Sinovac Hepatitis A VaccineSales, Sales Value (Million USD), Price and Gross Profit
- 4.10.4 Sinovac SWOT Analysis
- 4.11 Shanghai Zerun Biotechnology
5 Market Performance for Manufacturers
- 5.1 Global Hepatitis A Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Global Hepatitis A Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Global Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Global Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 China Market Performance for Manufacturers
- 6.1.1 China Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 China Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 China Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 China Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 USA Market Performance for Manufacturers
- 6.2.1 USA Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 USA Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 USA Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 USA Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 Europe Market Performance for Manufacturers
- 6.3.1 Europe Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 Europe Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 Europe Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 Europe Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Japan Market Performance for Manufacturers
- 6.4.1 Japan Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Japan Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Japan Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Japan Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Korea Market Performance for Manufacturers
- 6.5.1 Korea Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Korea Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Korea Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Korea Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 India Market Performance for Manufacturers
- 6.6.1 India Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 India Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 India Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 India Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Southeast Asia Market Performance for Manufacturers
- 6.7.1 Southeast Asia Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Southeast Asia Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Southeast Asia Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Southeast Asia Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 South America Market Performance for Manufacturers
- 6.8.1 South America Hepatitis A Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 South America Hepatitis A Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 South America Hepatitis A Vaccine Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 South America Hepatitis A Vaccine Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Global Hepatitis A Vaccine Market Assessment by Regions (2014-2020)
- 7.1 Global Hepatitis A Vaccine Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Global Hepatitis A Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Global Hepatitis A Vaccine Price (USD/Unit) by Regions 2014-2020
- 7.4 Global Hepatitis A Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions
- 8.1 Global Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.2 China Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.3 USA Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 Europe Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.5 Japan Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.6 Korea Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.7 India Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Hepatitis A Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Manufacturing Plants Distribution
11 Consumer Analysis
- 11.1 Hospitals Industry
- 11.2 Other Medical Institutions Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Global Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Global Hepatitis A Vaccine Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 China Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 USA Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 Europe Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Japan Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Korea Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 India Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Southeast Asia Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.10 South America Hepatitis A Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 Liver Inactivated Vaccine
- 12.2.3 Live Attenuated Vaccine
- 12.3 Sales (K Units) Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Hospitals
- 12.3.3 Other Medical Institutions
- 12.4 Price (USD/Unit) and Gross Profit
- 12.4.1 Global Hepatitis A Vaccine Price (USD/Unit) Trend 2021-2026
- 12.4.2 Global Hepatitis A Vaccine Gross Profit Trend 2021-2026
13 Conclusion
According to XYZResearch study, over the next five years the Hepatitis A Vaccinemarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Hepatitis A Vaccinebusiness.
Hepatitis A Vaccine market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Hepatitis A Vaccine market competition by top manufacturers/players, with Hepatitis A Vaccine sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline
Merck Sharp & Dohme Corp
SANOFI PASTEUR S.A
Norvatis
Crucell Switzerland AG(Berna+Crucell)
China Academy of Medical Sciences
Changchun Institute of Biological Products
Zhejiang Pukang
ChangSheng
Sinovac
Shanghai Zerun Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liver Inactivated Vaccine
Live Attenuated Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hepatitis A Vaccine for each application, including
Hospitals
Other Medical Institutions
Feel free to let me know if you have any special requirements.